Medicinal chemistry, also known as pharmaceutical chemistry, is a branch of chemistry focused on the development of new drugs and the improvement of existing ones. It is an interdisciplinary field ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...
Simulations Plus' silico software boosts non-animal drug development and drives growth. Read here for an investment analysis ...
WEST PALM BEACH, Fla (CBS12) — One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure and prevent diseases. But what if they could ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
The Physicians Committee for Responsible Medicine applauds the Food and Drug Administration’s newly released draft guidance, ...
CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...
In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...
Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional. In an interview with Fox News Digital, Dr. Dave Latshaw, CEO ...
An update from Kazia Therapeutics ( ($KZIA) ) is now available. On December 2, 2025, Kazia Therapeutics announced a $50 million private placement ...